FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362546087> ?p ?o ?g. }

• W4362546087 abstract "<div>Abstract<p>Clinical responses to immunotherapy have been associated with augmentation of preexisting immune responses, manifested by heightened inflammation in the tumor microenvironment. However, many tumors have a noninflamed microenvironment, and response rates to immunotherapy in melanoma have been <50%. We approached this problem by utilizing immunotherapy (CTLA-4 blockade) combined with chemotherapy to induce local inflammation. In murine models of melanoma and prostate cancer, the combination of chemotherapy and CTLA-4 blockade induced a shift in the cellular composition of the tumor microenvironment, with infiltrating CD8⁺ and CD4⁺ T cells increasing the CD8/Foxp3 T-cell ratio. These changes were associated with improved survival of the mice. To translate these findings into a clinical setting, 26 patients with advanced melanoma were treated locally by isolated limb infusion with the nitrogen mustard alkylating agent melphalan followed by systemic administration of CTLA-4 blocking antibody (ipilimumab) in a phase II trial. This combination of local chemotherapy with systemic checkpoint blockade inhibitor resulted in a response rate of 85% at 3 months (62% complete and 23% partial response rate) and a 58% progression-free survival at 1 year. The clinical response was associated with increased T-cell infiltration, similar to that seen in the murine models. Together, our findings suggest that local chemotherapy combined with checkpoint blockade–based immunotherapy results in a durable response to cancer therapy. <i>Cancer Immunol Res; 6(2); 189–200. ©2018 AACR</i>.</p></div>" @default.
• W4362546087 created "2023-04-06" @default.
• W4362546087 creator A5000207278 @default.
• W4362546087 creator A5002951130 @default.
• W4362546087 creator A5002954478 @default.
• W4362546087 creator A5006191181 @default.
• W4362546087 creator A5007569359 @default.
• W4362546087 creator A5009105564 @default.
• W4362546087 creator A5015970952 @default.
• W4362546087 creator A5020106808 @default.
• W4362546087 creator A5030125111 @default.
• W4362546087 creator A5041028510 @default.
• W4362546087 creator A5047117233 @default.
• W4362546087 creator A5048900201 @default.
• W4362546087 creator A5052270503 @default.
• W4362546087 creator A5054656505 @default.
• W4362546087 creator A5057908620 @default.
• W4362546087 creator A5064463300 @default.
• W4362546087 creator A5065920207 @default.
• W4362546087 creator A5071033599 @default.
• W4362546087 creator A5076803080 @default.
• W4362546087 creator A5076836211 @default.
• W4362546087 creator A5079949582 @default.
• W4362546087 creator A5090365102 @default.
• W4362546087 date "2023-04-03" @default.
• W4362546087 modified "2023-10-16" @default.
• W4362546087 title "Data from Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade" @default.
• W4362546087 doi "https://doi.org/10.1158/2326-6066.c.6549010.v1" @default.
• W4362546087 hasPublicationYear "2023" @default.
• W4362546087 type Work @default.
• W4362546087 citedByCount "0" @default.
• W4362546087 crossrefType "posted-content" @default.
• W4362546087 hasAuthorship W4362546087A5000207278 @default.
• W4362546087 hasAuthorship W4362546087A5002951130 @default.
• W4362546087 hasAuthorship W4362546087A5002954478 @default.
• W4362546087 hasAuthorship W4362546087A5006191181 @default.
• W4362546087 hasAuthorship W4362546087A5007569359 @default.
• W4362546087 hasAuthorship W4362546087A5009105564 @default.
• W4362546087 hasAuthorship W4362546087A5015970952 @default.
• W4362546087 hasAuthorship W4362546087A5020106808 @default.
• W4362546087 hasAuthorship W4362546087A5030125111 @default.
• W4362546087 hasAuthorship W4362546087A5041028510 @default.
• W4362546087 hasAuthorship W4362546087A5047117233 @default.
• W4362546087 hasAuthorship W4362546087A5048900201 @default.
• W4362546087 hasAuthorship W4362546087A5052270503 @default.
• W4362546087 hasAuthorship W4362546087A5054656505 @default.
• W4362546087 hasAuthorship W4362546087A5057908620 @default.
• W4362546087 hasAuthorship W4362546087A5064463300 @default.
• W4362546087 hasAuthorship W4362546087A5065920207 @default.
• W4362546087 hasAuthorship W4362546087A5071033599 @default.
• W4362546087 hasAuthorship W4362546087A5076803080 @default.
• W4362546087 hasAuthorship W4362546087A5076836211 @default.
• W4362546087 hasAuthorship W4362546087A5079949582 @default.
• W4362546087 hasAuthorship W4362546087A5090365102 @default.
• W4362546087 hasConcept C126322002 @default.
• W4362546087 hasConcept C143998085 @default.
• W4362546087 hasConcept C167672396 @default.
• W4362546087 hasConcept C170493617 @default.
• W4362546087 hasConcept C203014093 @default.
• W4362546087 hasConcept C21705690 @default.
• W4362546087 hasConcept C2776090121 @default.
• W4362546087 hasConcept C2776107976 @default.
• W4362546087 hasConcept C2776694085 @default.
• W4362546087 hasConcept C2777658100 @default.
• W4362546087 hasConcept C2777701055 @default.
• W4362546087 hasConcept C2778468042 @default.
• W4362546087 hasConcept C2779727006 @default.
• W4362546087 hasConcept C2780851360 @default.
• W4362546087 hasConcept C2781433595 @default.
• W4362546087 hasConcept C502942594 @default.
• W4362546087 hasConcept C71924100 @default.
• W4362546087 hasConcept C8891405 @default.
• W4362546087 hasConceptScore W4362546087C126322002 @default.
• W4362546087 hasConceptScore W4362546087C143998085 @default.
• W4362546087 hasConceptScore W4362546087C167672396 @default.
• W4362546087 hasConceptScore W4362546087C170493617 @default.
• W4362546087 hasConceptScore W4362546087C203014093 @default.
• W4362546087 hasConceptScore W4362546087C21705690 @default.
• W4362546087 hasConceptScore W4362546087C2776090121 @default.
• W4362546087 hasConceptScore W4362546087C2776107976 @default.
• W4362546087 hasConceptScore W4362546087C2776694085 @default.
• W4362546087 hasConceptScore W4362546087C2777658100 @default.
• W4362546087 hasConceptScore W4362546087C2777701055 @default.
• W4362546087 hasConceptScore W4362546087C2778468042 @default.
• W4362546087 hasConceptScore W4362546087C2779727006 @default.
• W4362546087 hasConceptScore W4362546087C2780851360 @default.
• W4362546087 hasConceptScore W4362546087C2781433595 @default.
• W4362546087 hasConceptScore W4362546087C502942594 @default.
• W4362546087 hasConceptScore W4362546087C71924100 @default.
• W4362546087 hasConceptScore W4362546087C8891405 @default.
• W4362546087 hasLocation W43625460871 @default.
• W4362546087 hasOpenAccess W4362546087 @default.
• W4362546087 hasPrimaryLocation W43625460871 @default.
• W4362546087 hasRelatedWork W2347177886 @default.
• W4362546087 hasRelatedWork W2782893986 @default.
• W4362546087 hasRelatedWork W3003217116 @default.
• W4362546087 hasRelatedWork W3003310139 @default.
• W4362546087 hasRelatedWork W3039388108 @default.
• W4362546087 hasRelatedWork W3091444202 @default.
• W4362546087 hasRelatedWork W3177607563 @default.

• next